2019 - Mays Cancer Center Annual Report

Physicians increasing HPV vaccine rates for populations with greatest cancer risk

Physicians/researchers are dedicated to educating males and childhood cancer survivors on their need for the HPV vaccine. While initial publicity campaigns targeted females, HPV causes cancer in both sexes and disproportionately in survivors.

GRACIAS Texas: Empowering South Texas’ underserved population

GRACIAS Texas (Genetic Risk Assessment for Cancer in All South Texas) is dedicated to cancer screening and cancer prevention education for thousands of residents living in the rural communities, towns and cities south of San Antonio.

FDA approves new drug to treat rare blood cancer myelofibrosis

Mays Cancer Center director is part of an international research team that developed a new drug to treat myelofibrosis, a rare blood cancer. The U.S. Food and Drug Administration approved the new drug.

Local clinician named 2019 MPN Hero for work on myeloproliferative neoplasms

CURE Media Group awarded a 2019 MPN Heroes award to Robyn Scherber, M.D., M.P.H., a nationally recognized clinician and hematologist, for her work in the field of rare blood cancers.

Medical oncologist Dr. Laura Tenner named health policy Fellow

The American Society of Clinical Oncology (ASCO) named Medical Oncologist Laura Tenner, M.D., M.P.H., a Health Policy Leadership Development Program Fellow for 2019-2020.

Mays Cancer Center Leadership Community Support

The Mays Cancer Center thanks all individuals, foundations and companies that support its missions to reduce the cancer burden in South Texas through the patient care, research, education, and cancer prevention programs focused on our unique population.